Takeda Pharmaceutical Company Limited (TKDA) — Free Cash Flow Generation Index
Takeda Pharmaceutical Company Limited (TKDA) has a Free Cash Flow Generation Index of 0.40x as of December 2025. Free cash flow of €150.88 Billion represents 0% of operating cash flow (€373.25 Billion). Explore Takeda Pharmaceutical Company Limited capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Takeda Pharmaceutical Company Limited Free Cash Flow Generation Index (2017–2025)
Historical FCF Generation Index trend for Takeda Pharmaceutical Company Limited across 9 annual periods. For the full cash flow conversion analysis, see Takeda Pharmaceutical Company Limited cash flow conversion.
Annual Free Cash Flow Generation for Takeda Pharmaceutical Company Limited (2017–2025)
Year-by-year Free Cash Flow Generation Index for Takeda Pharmaceutical Company Limited. Check Takeda Pharmaceutical Company Limited (TKDA) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.64x | €677.56 Billion | €1.06 Trillion | €379.62 Billion | ▲ +94.9% |
| 2024 | 0.33x | €235.61 Billion | €716.34 Billion | €480.73 Billion | ▼ -6.4% |
| 2023 | 0.35x | €343.47 Billion | €977.16 Billion | €633.69 Billion | ▼ -57.9% |
| 2022 | 0.83x | €937.07 Billion | €1.12 Trillion | €123.25 Billion | ▲ +8.9% |
| 2021 | 0.77x | €774.46 Billion | €1.01 Trillion | €111.21 Billion | ▲ +13.5% |
| 2020 | 0.67x | €452.04 Billion | €669.75 Billion | €127.08 Billion | ▲ +14.1% |
| 2019 | 0.59x | €194.37 Billion | €328.48 Billion | €77.68 Billion | ▼ -10.4% |
| 2018 | 0.66x | €249.59 Billion | €377.85 Billion | €67.00 Billion | ▼ -46.6% |
| 2017 | 1.24x | €323.02 Billion | €261.36 Billion | €61.66 Billion | — |